Most wasted peptide budget is decided at the sequence stage, long before the lab gets involved. EndoPhase gives you a read on the hydrophobic runs and motifs that tend to drive aggregation, for BPC-157 and any sequence you are weighing up.
Run BPC-157 preflightMost wasted peptide budget is decided at the sequence stage, long before the lab gets involved. For a candidate like BPC-157, the questions worth answering early are practical: is the sequence clean to make, is it stable, and does the intended route even make sense. aggregation risk is the part of that picture EndoPhase focuses on here.
For BPC-157, EndoPhase surfaces a read on the hydrophobic runs and motifs that tend to drive aggregation, in plain language, with the reasoning kept beside the result so a reviewer can agree or push back.
The cheapest time to catch a problem with a peptide is while it is still just text on a screen. The whole idea is to spend judgement before spending budget. Score it, document the reasoning, and keep the evidence attached for next time.
Request beta accessEndoPhase is research-use software. It does not sell peptides, give medical advice, diagnose, treat, or make claims about the safety or efficacy of any compound named here. Names are used as analysis subjects only.